Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |